The French Pavilion Sponsors & Partners
A major player in regional economic financing, supporting 1 in 5 SME and 1 in 3 mid-sized companies through its 110 Business Centers located across all regions of France and its
overseas territories (over $15 billion in financing by 2024). Caisse d’Epargne, a local cooperative banking network, supports businesses in their growth and transition projects. More than 38,000 businesses (SMEs, startups, mid-sized companies, and large corporate clients) are supported by our local experts, regardless of their size or industry.
Discover their dedicated sales teams: 400 relationship managers working closely with regional ecosystems to support your projects with responsiveness and expertise. A local support system reinforced by experts in cash management, international business, or innovation, for example. Being of service to you also means supporting you on your transformation journey and fully understanding your transition challenges, whether environmental, social, or governance-related.
Audrey Dubois
Head of the Public and Private Healthcare Division
Natixis Corporate & Investment Banking (part of Groupe BPCE the second largest banking group in France) is a global financial institution offering advisory, financing, and capital
markets services. Within Its Corporate & Investment Banking (CIB) division, the Healthcare Sector’team supports pharma, MedTech, and healthcare services with deep sector and scientific expertise.
Active across Europe, Natixis aims to be the go-to bank for healthcare clients. They focus on three specific areas: pharmaceuticals (big and midcap pharma, biotech), healthcare infrastructure and services (clinics, hospitals, nursing homes, laboratories, CDMO/CMO) and MedTech.
Antonin Rigaudière
Managing Director, Global Head of Healthcare Sector
IPSEN is a global biopharmaceutical company focused on discovering, developing, and commercializing transformative medicines in three key therapeutic areas: Oncology, Rare
Disease, and Neuroscience. Focused on areas of high unmet medical need, their team of 5,000 talented and dedicated professionals around the world work together every day to innovate for the benefit of patients and caregivers.
Philippe Lopes Fernandes
Executive Vice President, Chief Business Officer
Efor Group is a global leader in quality and regulatory compliance consulting for the Life Sciences industry. Founded in 2013, the company supports pharmaceutical, biotechnology,
and medical device organizations in securing their manufacturing operations and accelerating the delivery of innovative therapies to patients.
With more than 3,000 experts across 18 countries, Efor provides end-to-end solutions covering Commissioning, Qualification and Validation (CQV), Quality Management, and Engineering Compliance. Its approach combines deep technical expertise with a strong understanding of regulatory requirements, enabling clients to ensure the reliability, safety, and compliance of their production systems throughout the entire product lifecycle.
Mickael Pretot
Head of International
Founded in 2009 by Caroline de Mareuil-Villette and Claire Verschelde, ICOSA is a European intellectual property firm dedicated to health.
As a human size company which gathers 80 professionals, ICOSA is agile and responsive.Its teams are composed of 30 European IP attorneys (EPO and EUIPO) and 24 French IP attorneys (INPI) holding doctorates and/or engineering or law degrees from top French or European schools and universities.
Leveraging their scientific expertise and technical and legal skills, ICOSA’s experts master the specific challenges of intellectual property for each innovation or creation. Their attentive and highly available approach enables them to support their clients on a daily basis in decision-making and business growth.
Caroline De Mareuil Villette
Founding Partner
ORCOM US is a US based accounting and tax services firm with American Certified Public Accountants (CPAs), ACCA and French licensees.
ORCOM US world-class global team brings together the art of accounting and international taxation with the science of technology to help its clients achieve their personal or business goals. They drive their mission through a culture of excellence: constantly improving and learning, supporting performance, and succeeding with integrity.
Frédéric Blanchard
Partner
Shahin Gharakhanian Consulting LLC provides clinical and medical expertise for patient-focused drug and vaccine development, approval and launch programs. It is is a consulting company represented by Dr. Shahin Gharakhanian – a biotech executive with global experience across 30+ companies, 4 drug approvals, and leadership in Clinical Development & Medical Affairs. Dr. Gharakhanian has built pharma/CRO/academic units, advises CEOs, and chairs SABs and boards.
Shahin Gharakhanian
Principal & Founder
AIS is the flagship measure of the “Healthcare Innovation” program, and its role is to manage the implementation of the health component of France 2030 in conjunction with the relevant ministries and operators.
Clémentine Body
Director of Cross-Functional and International Projects
Atlanpole Biotherapies is the health competitiveness cluster for Western France (Brittany, Pays-de-la-Loire, Centre Val-de-Loire), accredited by the French Ministry of Industry in July 2005.
The cluster brings together industrial players, major groups, SMEs and start-ups, research laboratories, university teaching hospitals, universities and schools around a complete, relevant and competitive value chain for the health sector.
Capitalising on its solid local presence, strong growth momentum and high international profile, Atlanpole Biotherapies is resolutely taking up the challenge of tomorrow’s medicine, with a European strategy boosted by a policy of pooling resources with other healthcare clusters in order to achieve ambitious objectives in terms of business growth, collaborative R&D and international influence in the service of a French healthcare sector of excellence at global level.
More than 200 members are supported by the cluster in the following areas of excellence:
– Biotherapies / Biomanufacturing / Pharma
– Innovative medtechs
– Digital health
– Disease prevention
Elodie Girardet
Head of the Europe Unit
BOOST positions itself as a Global Health and DeepTech Campus of Innovation for Sciences and Industry addressing the OneHealth concept without focusing on any specific pathology « disease-agnostic ». This approach aims to stimulate innovation
at the intersections of disciplines such as Pharma-Biotech ; TechBio & AI ; Electronics ; MeMS & Semiconductors as enabling techno briks for the following subsectors like MedTech & Diagnostics; Robotics and Medical Equipment ; the Food-Agri-Tech & Cosmetics sectors.
Jean-Marc BOUREZ
Executive Director
CCI INTERNATIONAL GRAND EST is the operator for the support and international development of companies in the Grand Est region. As a gateway to all the services offered by Team France Export, CCI Grand-Est provides tailor-made
support to meet the needs of companies wishing to expand internationally.
Their team of export advisors, specialized by sector of activity, supports companies at each stage of their international development. CCI International Grand Est is leading the Grand Est business delegation at the BIO International Convention.
Valérie Mottl
Trade Advisor
At Choose Paris Region, their core mission is to assist international companies in their expansion plans.
From initial decision-making to setting up, and every step in between, they provide market insights, connections
and resources to support companies who want to develop their business activities in France. From market watch to implementation and re-invest, their goal is to help them take advantage of Paris Region’s exceptional talent and tech ecosystems to accelerate their growth.
Whether you need a specific service regarding one aspect of your expansion or full support throughout the project, they can help.
Their services are free, confidential, and customized. As an international company, you can access them at any stage of your project, regardless of the size of your company or its development stage. With their support, unlock business opportunities in Paris Region and get the most out of the Region’s assets.
Yann Masson
HealthTech & Sport Expert @ Choose Paris Region
Eurobiomed is the competitiveness cluster of the South of France, dedicated to Healthtech. Established in 2009 by all stakeholders in the healthcare sector from the regions of Sud Provence Alpes Côte d’Azur and Occitanie, Eurobiomed brings
together an ecosystem of over 400 industrial players, major corporations, SMEs, and startups, along with research laboratories and universities. They collaborate to develop and commercialize innovative products and services, aiming to generate growth and employment in promising markets.
Cécile Rousselot
Head of Strategic Projects
France Biotech was founded in 1997 as an independent association, uniting the country’s leading innovative health companies and their expert partners. As a leader in health innovation working in close cooperation with public authorities
in France and across Europe, France Biotech is ideally positioned to address the challenges facing the HealthTech sector (biotech, medtech & digital health), notably corporate financing, taxation on innovation and regulatory and market access-related issues.
Its committees and working groups strive to identify viable solutions to create the necessary conditions for a competitive and attractive industry. Its mission is to support HealthTech startups and SMEs in their quest for international expansion and give them the capability to rapidly design and develop new innovations and get them to the point of care.
Chloé Evans
Deputy Director General, Head of market research and international relations
France Deeptech is a non-profit association bringing together startups, investment funds, and research labs to build a sustainable deeptech ecosystem in France. They aim to turn French high-potential deeptech startups into international champions and solve major societal challenges.
Romain Roullois
General Manager
French Healthcare is an innovative public-private initiative aimed at bringing together under a single banner all the players in the French healthcare ecosystem (businesses, researchers, healthcare professionals, key public stakeholders, etc.)
to jointly promote their activities, expertise, technologies and innovations internationally.It helps to trigger a collective approach dynamic that stimulates international cooperation in the field of health and to promote the vision that health, a vector of social progress, must be improved for everyone everywhere in the world.
Julien Compiegne
French Healthcare Brand Manager
FACC San Diego/So-Cal is a non-profit institution whose mission is to boost French and American businesses and individuals to create a more connected community, by providing them with opportunities to reach their full potential in the U.S.
Sylvie Almeri
Managing Director
Genopole shapes and vivifies a research hub for genomics and life sciences, energizes the growth of biotechnologies by creating, accompanying and welcoming innovative businesses, strengthens a life sciences academic center, and organizes lively scientific events at the biocluster.
Laurence Lacroix
Partnerships and Business Development Director
Génother is a biocluster of excellence exclusively dedicated to gene therapy. They aim to accelerate the development of next-generation gene therapies from fundamental research to industrial production, while fostering breakthrough innovations in biomanufacturing.
Mélodie Dupré
Marketing and Partnerships
La French Tech San Diego is a unique movement bringing together startups, investors, policymakers and community builders. The mission? To make France one of the greatest places in the world to launch and grow global companies that make sense for our future.
Sylvie Almeri
Community Manager
As a French biocluster, Lyonbiopole Auvergne-Rhône-Alpes is the gateway to healthcare innovation in Auvergne-Rhône-Alpes, France. It aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies,
products and services to address global healthcare challenges.
In 2024, Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients.
Simon Gudin
Head of international affairs
MabDesign is a unique membership organization that supports the development of the French industrial sector in the field of biotherapies with business and scientific expertise. MabDesign provides strategic leverage and development opportunities for its 300, and growing, members. All and every action from MabDesign is based on their expertise in the biotherapy and bioproduction field.
Elsa Kress
Head of business development